Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹860.15
Market cap: ₹1,014 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 27.4×Sector 47.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 3 Management Change 2 Financial Results 2 Dividend 2 SME to Main Board Migration 1 Results Update 1 Merger & Restructuring 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

20 May 2026 15:25 IST NSE

Results Update

Remus Pharmaceuticals Results Update

Remus Pharmaceuticals reported FY26 revenue of ₹853.63 Crore, a 37.6% YoY increase. Strong growth in its B2C entity Relius drove exceptional financial performance and expansion.

Value: ₹853.6 Cr

Read the filing ↗